Cancel

Links to sites outside of xyjydb.com are provided as a resource to the audiences. Please note that Takeda is not responsible or liable for any third-party website 和 the website may not be appropriate for all audiences. 

To stay on the current website, select “Cancel”


Continue

You are leaving Takeda.com

&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;

&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的标志

Takeda - Global

EPD-3055 OneTrust Cookie

EPD-3519 Schema Script

EPD-2855 GTM Script

EPD-4037 Matomo Tag Manager

EPD-4268 Cookie Script Hack

我们的ESG报告会根据我们的透明度政策、实践和数据定期更新

我们的ESG报告会根据我们的透明度政策、实践和数据定期更新.

可持续发展披露|&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;制药

Divider Section

我们的ESG报告会根据我们的透明度政策、实践和数据定期更新.

我们将继续努力改进数据采集流程和ESG<a href='http://0zq9.xyjydb.com'>&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;</a>报告, 展示我们对透明度和持份者的承诺.





我们每天都在努力确保长期可持续增长、创新和韧性. 我们的年度综合报告概述了我们在2023财年为实现让People民更健康、让世界拥有更光明未来的目标所取得的进展.

## 2024 Annual Integrated Report

补充年度综合报告的完整指标清单可在《&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;》中找到.


## Takeda 2024 ESG Databook

## Downloadable index tables



[企业理念指标](http://assets-dam.xyjydb.com/image/upload/Global/Corporate-Responsibility/Corporate-Sustainability/Sustainability-Disclosures/2024/ESG_Metrics_en.pdf#page=4) 帮助我们实现可持续增长，并与外部利益相关者建立信任. 我们的愿景是发现并提供改变生命的治疗方法, 以我们对Patient的承诺为指导, People类与Planet. 这些迫切需要确定&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;必须在哪些领域投资以实现我们的目标. 我们的目标是通过使我们的行动符合这些要求，并释放数据和数字的力量，创造长期价值. 我们通过我们的企业理念指标来衡量我们的进步，每年披露结果.
阅读更多关于我们的企业理念 [在这里](/about/our-company/corporate-philosophy/).



## Corporate Philosophy Metrics

以下<a href='http://0zq9.xyjydb.com'>&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;</a>提供了我们在“患者”类别下的ESG披露的链接, People, Planet和基于价值观的治理.  





我们的方法:
<ul>
<li>[负责任地将科学转化为高度创新的、改变生活的药物和疫苗](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/sustainability-disclosures/responsibly-translate-science/)</li>
<li>[道德](http://0zq9.xyjydb.com/about/corporate-responsibility/ethics-disclosures/ethics/)</li>
<li>[及时、广泛和可持续获取](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/timely-broad-and-sustainable-access/)</li>
<li>[获得药品](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/access-to-medicine/)</li>
<li>[我们对患者的承诺](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/patients/)</li>
</ul>

我们的立场:
<ul>
<li>[我们对生物科技的立场](http://assets-dam.xyjydb.com/raw/upload/v1675193355/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/2021-takeda-position-on-biotechnology_en.pdf)</li>
<li>[我们对伪造医疗产品的立场](http://assets-dam.xyjydb.com/image/upload/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/Position_Falsified_Medical_Products.pdf)</li>
<li>[我们对全球定价的立场](http://assets-dam.xyjydb.com/raw/upload/v1675193360/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/takeda-position-on-global-pricing-eg.pdf)</li>
<li>[我们对基于价值的医疗保健的立场](http://assets-dam.xyjydb.com/image/upload/v1684839809/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/Position_Value-based-Healthcare.pdf)</li>
<li>[我们对卫生公平的立场](http://assets-dam.xyjydb.com/image/upload/Global/Corporate-Responsibility/Positions/Health_Equity.pdf)</li>
<li>[我们对药品可及性的立场](http://assets-dam.xyjydb.com/image/upload/v1677028367/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/Position_Access_to_Medicines_New_Template.pdf)</li>
<li>[我们对知识产权促进药品获取的立场](http://assets-dam.xyjydb.com/raw/upload/v1675193354/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/2020-takeda-position-ip-for-access-to-medicine-en_final.pdf)</li>
<li>[我们对卫生数据共享和再利用的立场](http://assets-dam.xyjydb.com/raw/upload/v1675193360/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/takeda_position_data-sharing-and-reuse.pdf)</li>
</ul>

更多关于我们的工作:
<ul>
<li>[研究 & 发展](http://0zq9.xyjydb.com/science/research-and-development/)</li>
<li>[联盟 & 合作伙伴关系](http://0zq9.xyjydb.com/science/research-and-development/partnerships/)</li>
<li>[重点领域](http://0zq9.xyjydb.com/science/areas-of-focus/)</li>
<li>[制造业](http://0zq9.xyjydb.com/science/products/manufacturing/)</li>
<li>[获得药品](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/access-to-medicine/)</li>
<li>[企业社会责任的伙伴关系](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-giving/programs-in-action/)</li>
<li>[我们的你.S. 定价的哲学](http://0zq9.xyjydb.com/en-us/who-we-are/takeda-pricing-philosophy/)</li>
</ul>


## Patient



<ul>
<li>我们的方法: [People才管理](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/talent-management/)</li>
<li>更多关于我们在招聘和留住科学家和研发People员方面所做的工作: [SASB指数报告2024](http://assets-dam.xyjydb.com/image/upload/Global/Corporate-Responsibility/Corporate-Sustainability/Sustainability-Disclosures/2024/SASB_en.pdf)</li>
<li>更多关于我们的<a href='http://0zq9.xyjydb.com'>&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;</a>: [全球环境、健康和安全政策](http://assets-dam.xyjydb.com/image/upload/v1705078449/legacy-dotcom/siteassets/system/corporate-responsibility/environment/Global_EHS_Policy_and_Position_English.pdf)</li>
</ul>

## People




我们的立场:
<ul>
<li>[我们对气候变化的立场](http://assets-dam.xyjydb.com/raw/upload/v1662721237/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/Takeda_Position_climate_change_2020.pdf)</li>
<li>[我们对水资源管理的立场](http://assets-dam.xyjydb.com/raw/upload/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/position-on-water-stewardship-final-24jun22.pdf)</li>
<li>[我们对生物多样性的立场](http://assets-dam.xyjydb.com/image/upload/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/Position_Biodiversity_New_EN_Final_24MAR.pdf)</li>
<li>[我们对负责任地使用塑料的立场](http://assets-dam.xyjydb.com/image/upload/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/Position_Plastics_New_EN_Final_24MAR.pdf)</li>
<li>[我们对环境中的药品的立场](http://assets-dam.xyjydb.com/raw/upload/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/position-on-pie-final-24jun22.pdf)</li>
</ul>

我们的故事:
<ul>
<li>[可持续发展的产品](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/products/)</li>
<li>[浪费](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/waste/)</li>
<li>[脱碳](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/decarbonizing/)</li>
<li>[水](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/water/)</li>
<li>[生物多样性](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/stories/biodiversity/)</li>
</ul>

更多关于我们的工作:
<ul>
<li>资源循环和产品回收: [SASB指数报告2024](http://assets-dam.xyjydb.com/image/upload/Global/Corporate-Responsibility/Corporate-Sustainability/Sustainability-Disclosures/2024/SASB_en.pdf)
</li> 
<li>[我们的TCFD报告](http://assets-dam.xyjydb.com/image/upload/legacy-dotcom/siteassets/system/corporate-responsibility/environment/Takeda_2022_TCFD_Report.pdf)</li>
<li>[我们对Planet的承诺](http://0zq9.xyjydb.com/about/corporate-responsibility/corporate-sustainability/sustainability-approach/planet/)</li>
<li>[水管理，塑料，生物多样性，制药在环境和生态设计](http://assets-dam.xyjydb.com/raw/upload/v1668757019/legacy-dotcom/siteassets/system/corporate-responsibility/environment/takeda-approach-to-key-sustainability-topics.pdf)</li>
<li>[&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;自愿补偿和EAC采购的历史记录](http://assets-dam.xyjydb.com/image/upload/v1708608641/Global/Corporate-Responsibility/Corporate-Sustainability/Sustainability-Disclosures/Historical_Record_of_Takeda_Voluntary_Offset_and_EAC_Purchases.pdf)</li>
</ul>

更多关于我们的<a href='http://0zq9.xyjydb.com'>&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;</a>:
<ul>
<li>[全球环境、健康和安全政策](http://assets-dam.xyjydb.com/image/upload/v1705078449/legacy-dotcom/siteassets/system/corporate-responsibility/environment/Global_EHS_Policy_and_Position_English.pdf)</li>
</ul>

## Planet



*   我们的方法: [公司治理](/about/corporate-governance/strategy)

更多关于我们的<a href='http://0zq9.xyjydb.com'>&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;</a>: 

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;执行团队(TET)](/about/leadership)

*   [董事会](/about/board-of-directors) 

*   [租章及报告](/about/corporate-governance/charters-and-reports)



*   股东周年大会资料, 包括决议通知和行使投票权的结果; [年度股东大会](/investors/events)

*   有关总奖励和补偿的<a href='http://0zq9.xyjydb.com'>&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;</a>，请参见 [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;高管薪酬概述](http://assets-dam.xyjydb.com/raw/upload/v1662727590/legacy-dotcom/siteassets/system/investors/shareholders-meetings/sm_146_04_en.pdf) 和 [企业管治报告](/about/corporate-governance/charters-and-reports)

公司治理

*   [我们对税收的立场](http://assets-dam.xyjydb.com/image/upload/v1711390793/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/Position_Taxation.pdf)
*   [税务披露总额](http://assets-dam.xyjydb.com/image/upload/Global/Corporate-Responsibility/Corporate-Sustainability/Sustainability-Disclosures/tttc-en.pdf)



税收

*   我们的品质管理方法: [道德](/about/corporate-responsibility/ethics-disclosures/ethics/)

*   [我们对伪造医疗产品的立场](http://assets-dam.xyjydb.com/image/upload/v1684891388/legacy-dotcom/siteassets/system/who-we-are/companyinformation/positions--guidelines/Position_Falsified_Medical_Products.pdf)

*   有安全警示的<a href='http://0zq9.xyjydb.com'>&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;</a>产品可在 [FDA MedWatchPeople类医疗产品安全警报数据库](http://www.fda.gov/safety/medwatch-fda-safety-information-and-adverse-event-reporting-program)

*   历史产品召回可以在 [FDA药品召回数据库](http://www.食品及药物管理局.gov /药品/ drug-safety-和-availability /药品召回?search_api_fulltext =&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;&field_terminated_recall =所有)



质量管理

*   我们的方法: [供应商](/science/products/suppliers)

*   更多关于我们的<a href='http://0zq9.xyjydb.com'>&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;</a>: [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;供应商行为准则](http://assets-dam.xyjydb.com/raw/upload/v1675187395/legacy-dotcom/siteassets/system/what-we-do/suppliers/supplier-code-conduct/pdf/supplier-code-of-conduct-english.pdf)



供应链

*   我们的方法:  [道德 ](/about/corporate-responsibility/ethics-disclosures/ethics)(包括医学伦理、生物伦理和People权)

更多关于我们的<a href='http://0zq9.xyjydb.com'>&#32593;&#25237;&#20449;&#35465;&#27604;&#36739;&#22909;&#30340;&#24179;&#21488;</a>:

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;全球行为准则](http://assets-dam.xyjydb.com/raw/upload/v1675193384/legacy-dotcom/siteassets/system/who-we-are/corporate-governance/compliance/coc_digital-booklet_external.pdf)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;伦理线](http://secure.ethicspoint.com/domain/media/en/gui/28267/index.html)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;对临床试验的承诺](http://clinicaltrials.xyjydb.com/takedas-commitment?commitment)

*   更多关于我们在临床试验参与者安全方面所做的工作: [SASB指数报告2024](http://assets-dam.xyjydb.com/image/upload/Global/Corporate-Responsibility/Corporate-Sustainability/Sustainability-Disclosures/2024/SASB_en.pdf)

更多关于我们对待People权的态度: 

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;的People权承诺](http://assets-dam.xyjydb.com/image/upload/v1685641724/Global/Ethics/Takeda_Human_Rights_Commitment.pdf) 

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;英国、澳大利亚和加拿大23财年现代奴隶制声明](http://assets-dam.xyjydb.com/image/upload/v1717173034/Global/Corporate-Responsibility/Corporate-Sustainability/Sustainability-Disclosures/Takeda-UK-Australia-and-Canada-Modern-Slavery-Statement-for-FY23.pdf)

*   [&#21313;&#22823;&#32593;&#36172;&#24179;&#21488;AS挪威透明度法案报告23财年](http://assets-dam.xyjydb.com/image/upload/Global/Ethics/Takeda_Norway_Transparency_Act_Financial_Year_2023.pdf) 



道德

*   我们的方法: [风险 & 危机管理](/about/corporate-responsibility/ethics-disclosures/ethics/#ethics-across-our-business)

*   与内部控制和风险管理制度有关的事项; [企业管治报告](/about/corporate-governance/charters-and-reports)

*   [我们对公共政策参与的立场](http://assets-dam.xyjydb.com/image/upload/v1695703484/Global/Corporate-Responsibility/Positions/takeda-position-on-public-policy-engagement_en.pdf)



风险 & 危机管理

*   我们的方法: [公司给](/about/corporate-responsibility/corporate-giving)

更多关于我们的工作:

*   [企业社会责任行动计划](/about/corporate-responsibility/corporate-giving/programs-in-action)

*   [全球企业社会责任项目申请流程](/about/corporate-responsibility/funding)

